Skip to content
DaveManuel.com · Institutional Ownership · Who Owns It

GALMED PHARMACEUTICALS LTD (GLMD)

Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.

14
Reporting holders
$85.9K
Reported value
0.0%
Calls
0.0%
Puts
+0
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
CITADEL ADVISORS LLC$48.3K86,8510.00%4q+663.1%+$42.0K
HRT FINANCIAL LP$23.0K42,0900.00%newNEW
XTX Topco Ltd$8.4K15,0150.00%3q-33.0%-$4.1K
TWO SIGMA SECURITIES, LLC$6.1K11,0120.00%3q-8.0%
SBI Securities Co., Ltd.$37660.00%7q+312.5%
MORGAN STANLEY$31560.00%8q-64.3%
WELLS FARGO & COMPANY/MN$24430.00%8qHELD
Federation des caisses Desjardins du Quebec$8140.00%8qHELD
Allworth Financial LP$220.00%8qHELD
UBS Group AG$230.00%8q-99.9%-$1.7K
OSAIC HOLDINGS, INC.$250.00%8qHELD
ELEVATION WEALTH PARTNERS, LLC$110.00%8qHELD
ROYAL BANK OF CANADA$05500.00%newNEW
TSFG, LLC$0170.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202614$85.9K155,7253240.0%
Q1 202614$71.2K145,7550450.0%
Q4 202516$166.4K221,6605310.0%
Q3 202513$102.0K72,8243030.0%
Q2 202514$140.2K75,9874310.0%
Q1 202512$80.4K55,8762040.0%
Q4 202411$142.8K44,7672210.0%
Q3 20249$38.3K5,5859000.0%
Q2 202411$112.9K396,7311140.0%
Q1 202411$67.6K201,4522040.0%
Q4 202312$286.3K629,2560240.0%
Q3 202317$429.2K691,4398300.0%
Q2 202312$419.1K143,53712000.0%
Q1 202321$878.3K2,061,9314240.0%
Q4 202221$1.2M2,426,15442100.0%
Q3 202221$798.4K2,566,4974370.0%
Q2 202220$1.7M2,519,6843720.5%
Q1 202223$4.5M2,809,6174241.0%
Q4 202123$8.2M4,006,69253511.4%
Q3 202124$12.4M4,227,9223654.5%
Q2 202124$14.9M4,812,09223101.7%
Q1 202129$19.5M5,660,7789450.3%
Q4 202021$19.5M6,274,6583650.0%
Q3 202023$27.0M7,646,4153640.0%
Q2 202025$40.2M8,419,1652830.0%
Q1 202032$28.0M8,152,86641070.0%
Q4 201932$39.9M6,906,7617860.0%
Q3 201930$34.9M7,301,6843670.0%
Q2 201933$64.7M8,766,66031290.3%
Q1 201934$68.9M8,415,36057100.2%
Q4 201843$784.6M114,852,3934110.0%